Bo Feng from 2127 Stratford Ln, Glenview, IL 60026, age 41

Medicine Doctors

Bo Feng

view source

Specialties:

Pathology
Blood Banking & Transfusion Medicine
Anatomic Pathology
Anatomic Pathology & Clinical Pathology
Hematology
Hematology

Education:

Tongji Medical University (1985)

Resumes

Planning Intern At Greater North Michigan Avenue Association (Gnmaa)

view source

Location:

Greater Chicago Area

Industry:

Architecture & Planning

Work:

Greater North Michigan Avenue Association (GNMAA) - Greater Chicago Area Jan 2012 - Jun 2012
Planning Intern
Arup Shanghai - Shanghai 2009 - 2010
Planning Intern

Education:

University of Illinois at Chicago 2010 - 2012
East China Normal University 2006 - 2010
Bachelor, Urban Planning and Resource Management

Skills:

SketchUp
Urban Planning
GIS
SPSS

Bo Feng

view source

Location:

3034 south Wentworth Ave, Chicago, IL 60616

Industry:

Computer Software

Work:

Fermilab Jun 2019 - Aug 2019
Computational Science Intern
Indiana University Jun 2019 - Aug 2019
Phd Student
Capital One Jan 2017 - Jul 2017
Software Engineer and Senior Associate
Rnet Technologies, Inc. Feb 2016 - Dec 2016
Software Engineer
Illinois Institute of Technology Sep 2013 - Nov 2015
Research Assistant

Education:

Indiana University Bloomington 2017
Doctorates, Doctor of Philosophy, Engineering, Philosophy Illinois Institute of Technology 2011 - 2014
Master of Science, Masters, Computer Science China Agricultural University 2003 - 2007
Bachelors, Engineering Indiana University

Skills:

C++
Java
Python
Distributed Systems
C
Linux
Hadoop
Eclipse
Software Engineering
Shell Scripting
Git
Javascript
Sql
Mysql
Programming
Bash
Mpi
Html
Apache Spark
Oop
Software Development
Databases
Jquery
Web Development
Research
Operating Systems
Php
Xml
J2Ee
Unix
Ajax
Android
Core Java
Mootools
Ant
Junit
Object Oriented Design
Mpio
Rest
Spring
Subversion
Json
Latex
Jdbc
Netbeans
Angularjs
Computer Science
Css
Hibernate
Algorithms

Interests:

Social Services
Economic Empowerment
Politics
Education
Environment
Science and Technology
Health

Languages:

English
Mandarin

Group Manager, Reactor And Fuel Cycle Analysis

view source

Location:

Chicago, IL

Industry:

Research

Work:

Argonne National Laboratory
Group Manager, Reactor and Fuel Cycle Analysis
Argonne National Laboratory Apr 1, 2016 - May 2019
Principal Nuclear Engineer
Argonne National Laboratory Jul 2011 - Apr 2016
Nuclear Engineer
Forschungszentrum Karlsruhe Jun 2007 - Aug 2007
Intern
Westinghouse Electric Company Jun 2006 - Aug 2006
Intern

Education:

Massachusetts Institute of Technology 2008 - 2011
Doctorates, Doctor of Philosophy, Engineering Massachusetts Institute of Technology 2003 - 2008
Massachusetts Institute of Technology 2007 - 2008
Massachusetts Institute of Technology 2007
Monroe Woodbury High School

Skills:

Nuclear
Physics
Modeling
Simulations
Matlab
Engineering
Nuclear Engineering
Research
Reactor
Analysis

Interests:

Traveling
Golf
Green Bay Packers
Fantasy Football

Languages:

Mandarin
French

Software Engineer

view source

Location:

Chicago, IL

Industry:

Information Technology And Services

Work:

Snap Inc.
Software Engineer
Linkedin Aug 1, 2015 - Aug 2017
Staff Software Engineer
Allston Trading Feb 2009 - Jul 2015
Senior Trading System Developer
Marvell Semiconductor Mar 2007 - Jan 2009
R and D Engineer
Ibm Aug 2004 - Mar 2007
R and D Engineer

Education:

Tsinghua University 1997 - 2004
Master of Science, Masters, Computer Science

Skills:

Algorithms
Java
C++
Multithreading
C
Embedded Systems
Distributed Systems

Interests:

Networking Programming

Bo Feng

view source

Bo Feng

view source

Student At University Of Illinois At Chicago

view source

Location:

Greater Chicago Area

Industry:

Architecture & Planning

Education:

University of Illinois at Chicago 2010 - 2012

Us Patents

Compositions And Methods Relating To Abca1-Mediated Cholesterol Efflux
view source
US Patent:

20030235878, Dec 25, 2003
Filed:

Apr 30, 2003
Appl. No.:

10/426415
Inventors:

Ira Tabas - New City NY, US
Bo Feng - Teaneck NJ, US
International Classification:

C12Q001/60
US Classification:

435/011000
Abstract:

This invention provides a method for determining whether an agent increases ABCA1-dependent cholesterol efflux from a cell. This invention also provides methods for increasing cholesterol efflux from a cell and for decreasing the amount of cholesterol in a cell. This invention further provides methods for increasing the likelihood that a cholesterol-loaded macrophage will survive and for decreasing the likelihood that a cholesterol-loaded macrophage will contribute to the progression of atherosclerosis. Finally, this invention provides a method for treating a subject afflicted with atherosclerosis, and a related article of manufacture.